0001127602-12-017238.txt : 20120517 0001127602-12-017238.hdr.sgml : 20120517 20120517163042 ACCESSION NUMBER: 0001127602-12-017238 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120516 FILED AS OF DATE: 20120517 DATE AS OF CHANGE: 20120517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DODION PIERRE F CENTRAL INDEX KEY: 0001403174 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21696 FILM NUMBER: 12852329 MAIL ADDRESS: STREET 1: ARIAD PHARMACEUTICALS INC STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884731 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 223106987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174940400 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 form4.xml PRIMARY DOCUMENT X0305 4 2012-05-16 0000884731 ARIAD PHARMACEUTICALS INC ARIA 0001403174 DODION PIERRE F C/O ARIAD PHARMACEUTICALS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 1 SVP, Corp. Dev. & Operations Common Stock 2012-05-16 4 S 0 22130 17.50 D 36640 D Common Stock 0 I Wife This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2011. /s/Edward M. Fitzgerald, Attorney-in-Fact 2012-05-17